Compare $ATYR vs $SHPH | Chartloom

Compare

$ATYR vs $SHPH

aTyr Pharma Inc · Shuttle Pharmaceuticals Holdings Inc

ATYR

aTyr Pharma Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Compare $ATYR vs $SHPH

Comparing aTyr Pharma Inc and Shuttle Pharmaceuticals Holdings Inc

ATYRaTyr Pharma Inc

SHPHShuttle Pharmaceuticals Holdings Inc

ATYRaTyr Pharma Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.1%

YTD performance

-67.6%

52W performance

-75.4%

FCF yield

-227.1%

SHPHShuttle Pharmaceuticals Holdings Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.6%

52W performance

-87.9%

FCF yield

-283.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATYR

SHPH

Detailed metrics comparison

ATYR

aTyr Pharma Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

ATYR$24M

SHPH$3M

Enterprise Value

ATYR$9M

SHPH$3M

Price

ATYR$0.25

SHPH$5.33

P/E Ratio

ATYRN/A

SHPHN/A

P/S Ratio

ATYR127.05x

SHPH0.00x

EV/Sales

ATYR44.92x

SHPH0.00x

EV/EBITDA

ATYR0.00x

SHPH0.00x

P/B Ratio

ATYR0.58x

SHPH5.94x

P/FCF Ratio

ATYRN/A

SHPHN/A

EV/FCF

ATYR-0.16x

SHPH-0.34x

PEG Ratio

ATYRN/A

SHPHN/A

Forward P/E (NTM)

ATYRN/A

SHPHN/A

Forward P/S (NTM)

ATYRN/A

SHPHN/A

Revenue (TTM)

ATYR$190K

SHPH$0

Revenue Growth (YoY)

ATYR-19.1%

SHPHN/A

Forward Rev Growth

ATYR2461.0%

SHPH0.0%

Gross Margin (TTM)

ATYR0.0%

SHPH0.0%

Operating Margin (TTM)

ATYR0.0%

SHPH0.0%

EBITDA Margin (TTM)

ATYR-21689.5%

SHPH0.0%

Net Margin (TTM)

ATYR-20898.4%

SHPH0.0%

FCF Margin (TTM)

ATYR-28852.1%

SHPHN/A

Net Income (TTM)

ATYR$-40M

SHPH$-10M

FCF (TTM)

ATYR$-55M

SHPH$-10M

EPS (TTM)

ATYR$0.00

SHPH-$10.11

ROE (TTM)

ATYR-9962.0%

SHPH-40833.0%

ROA (TTM)

ATYR-7441.0%

SHPH-13815.0%

ROIC (TTM)

ATYR-9817.0%

SHPH-37757.0%

Cash

ATYR$16M

SHPH$90K

Debt

ATYR$554K

SHPH$0

Net Cash/Debt

ATYR$16M

SHPH$90K

Current Ratio (TTM)

ATYR5.12x

SHPH0.30x

Quick Ratio (TTM)

ATYR5.08x

SHPH0.13x

Debt/Equity (TTM)

ATYR0.01x

SHPH1.23x

Debt/Assets (TTM)

ATYR0.0%

SHPH0.0%

Interest Coverage (TTM)

ATYRN/A

SHPHN/A

Net Debt/EBITDA (TTM)

ATYR0.00x

SHPH0.00x

Beta

ATYR0.99

SHPH1.13

52W Performance

ATYR-75.4%

SHPH-87.9%

YTD Performance

ATYR-67.6%

SHPH-70.6%

% from 52W High

ATYR-78.0%

SHPH-90.5%

% from 52W Low

ATYR0.1%

SHPH106.9%

Asset Turnover (TTM)

ATYR0.00x

SHPH0.00x

FCF Yield (TTM)

ATYR-227.1%

SHPH-283.7%

Earnings Yield (TTM)

ATYR-164.5%

SHPH-300.8%

Dividend Yield (TTM)

ATYRN/A

SHPHN/A

Rule of 40

ATYR-28,871.3

SHPH0.0

EV/GP/RG

ATYRN/A

SHPHN/A

Ticker research

View ATYR research View SHPH research

Metric	ATYR aTyr Pharma Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$24M	$3M
Enterprise Value	$9M	$3M
Price	$0.25	$5.33
P/E Ratio	N/A	N/A
P/S Ratio	127.05x	0.00x
EV/Sales	44.92x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.58x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.16x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$190K	$0
Revenue Growth (YoY)	-19.1%	N/A
Forward Rev Growth	2461.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-21689.5%	0.0%
Net Margin (TTM)	-20898.4%	0.0%
FCF Margin (TTM)	-28852.1%	N/A
Net Income (TTM)	$-40M	$-10M
FCF (TTM)	$-55M	$-10M
EPS (TTM)	$0.00	-$10.11
ROE (TTM)	-9962.0%	-40833.0%
ROA (TTM)	-7441.0%	-13815.0%
ROIC (TTM)	-9817.0%	-37757.0%
Financial Health
Cash	$16M	$90K
Debt	$554K	$0
Net Cash/Debt	$16M	$90K
Current Ratio (TTM)	5.12x	0.30x
Quick Ratio (TTM)	5.08x	0.13x
Debt/Equity (TTM)	0.01x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	1.13
52W Performance	-75.4%	-87.9%
YTD Performance	-67.6%	-70.6%
% from 52W High	-78.0%	-90.5%
% from 52W Low	0.1%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-227.1%	-283.7%
Earnings Yield (TTM)	-164.5%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-28,871.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATYR research	View SHPH research

Valuation

P/S Ratio

SHPH

0.00x

ATYR

127.05x

EV/FCF

SHPH

-0.34x

ATYR

-0.16x

Growth & revenue

Revenue Growth TTM

ATYR

-19.1%

Forward Revenue Growth

ATYR

2461.0%

SHPH

0.0%

Profitability & performance

Gross Margin

ATYR

0.0%

SHPH

0.0%

ROE

ATYR

-9962.0%

SHPH

-40833.0%

FCF Yield %

ATYR

-227.1%

SHPH

-283.7%

52-Week Performance

ATYR

-75.4%

SHPH

-87.9%

Detailed metrics comparison

ATYR

aTyr Pharma Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

ATYR$24M

SHPH$3M

Enterprise Value

ATYR$9M

SHPH$3M

Price

ATYR$0.25

SHPH$5.33

P/E Ratio

ATYRN/A

SHPHN/A

P/S Ratio

ATYR127.05x

SHPH0.00x

EV/Sales

ATYR44.92x

SHPH0.00x

EV/EBITDA

ATYR0.00x

SHPH0.00x

P/B Ratio

ATYR0.58x

SHPH5.94x

P/FCF Ratio

ATYRN/A

SHPHN/A

EV/FCF

ATYR-0.16x

SHPH-0.34x

PEG Ratio

ATYRN/A

SHPHN/A

Forward P/E (NTM)

ATYRN/A

SHPHN/A

Forward P/S (NTM)

ATYRN/A

SHPHN/A

Revenue (TTM)

ATYR$190K

SHPH$0

Revenue Growth (YoY)

ATYR-19.1%

SHPHN/A

Forward Rev Growth

ATYR2461.0%

SHPH0.0%

Gross Margin (TTM)

ATYR0.0%

SHPH0.0%

Operating Margin (TTM)

ATYR0.0%

SHPH0.0%

EBITDA Margin (TTM)

ATYR-21689.5%

SHPH0.0%

Net Margin (TTM)

ATYR-20898.4%

SHPH0.0%

FCF Margin (TTM)

ATYR-28852.1%

SHPHN/A

Net Income (TTM)

ATYR$-40M

SHPH$-10M

FCF (TTM)

ATYR$-55M

SHPH$-10M

EPS (TTM)

ATYR$0.00

SHPH-$10.11

ROE (TTM)

ATYR-9962.0%

SHPH-40833.0%

ROA (TTM)

ATYR-7441.0%

SHPH-13815.0%

ROIC (TTM)

ATYR-9817.0%

SHPH-37757.0%

Cash

ATYR$16M

SHPH$90K

Debt

ATYR$554K

SHPH$0

Net Cash/Debt

ATYR$16M

SHPH$90K

Current Ratio (TTM)

ATYR5.12x

SHPH0.30x

Quick Ratio (TTM)

ATYR5.08x

SHPH0.13x

Debt/Equity (TTM)

ATYR0.01x

SHPH1.23x

Debt/Assets (TTM)

ATYR0.0%

SHPH0.0%

Interest Coverage (TTM)

ATYRN/A

SHPHN/A

Net Debt/EBITDA (TTM)

ATYR0.00x

SHPH0.00x

Beta

ATYR0.99

SHPH1.13

52W Performance

ATYR-75.4%

SHPH-87.9%

YTD Performance

ATYR-67.6%

SHPH-70.6%

% from 52W High

ATYR-78.0%

SHPH-90.5%

% from 52W Low

ATYR0.1%

SHPH106.9%

Asset Turnover (TTM)

ATYR0.00x

SHPH0.00x

FCF Yield (TTM)

ATYR-227.1%

SHPH-283.7%

Earnings Yield (TTM)

ATYR-164.5%

SHPH-300.8%

Dividend Yield (TTM)

ATYRN/A

SHPHN/A

Rule of 40

ATYR-28,871.3

SHPH0.0

EV/GP/RG

ATYRN/A

SHPHN/A

Ticker research

View ATYR research View SHPH research

Metric	ATYR aTyr Pharma Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$24M	$3M
Enterprise Value	$9M	$3M
Price	$0.25	$5.33
P/E Ratio	N/A	N/A
P/S Ratio	127.05x	0.00x
EV/Sales	44.92x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.58x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.16x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$190K	$0
Revenue Growth (YoY)	-19.1%	N/A
Forward Rev Growth	2461.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-21689.5%	0.0%
Net Margin (TTM)	-20898.4%	0.0%
FCF Margin (TTM)	-28852.1%	N/A
Net Income (TTM)	$-40M	$-10M
FCF (TTM)	$-55M	$-10M
EPS (TTM)	$0.00	-$10.11
ROE (TTM)	-9962.0%	-40833.0%
ROA (TTM)	-7441.0%	-13815.0%
ROIC (TTM)	-9817.0%	-37757.0%
Financial Health
Cash	$16M	$90K
Debt	$554K	$0
Net Cash/Debt	$16M	$90K
Current Ratio (TTM)	5.12x	0.30x
Quick Ratio (TTM)	5.08x	0.13x
Debt/Equity (TTM)	0.01x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	1.13
52W Performance	-75.4%	-87.9%
YTD Performance	-67.6%	-70.6%
% from 52W High	-78.0%	-90.5%
% from 52W Low	0.1%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-227.1%	-283.7%
Earnings Yield (TTM)	-164.5%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-28,871.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATYR research	View SHPH research